THEMISMED

Themis Medicare Share PriceThemis Medicare

₹179.7
-2.15 (-1.18%)
As on 11 December, 2023 | 11:58 BSE: 530199 NSE: THEMISMEDISIN: INE083B01024

Themis Medicare Performance

Day Range

  • Low 178.40
  • High 184.60
₹ 179.7

52 Week Range

  • Low 106.06
  • High 197.17
₹ 179.7
  • Open Price182.00
  • Previous Close181.85
  • Volume34365

Start SIP in Themis Medicare

Start SIP

Themis Medicare Share Price

  • Over 1 Month 6.02%
  • Over 3 Month 12.27%
  • Over 6 Month 21.83%
  • Over 1 Year 59.76%

Themis Medicare Key Statistics

P/E Ratio 32.3
PEG Ratio -2.9
Market Cap Cr 1,654
Price to Book Ratio 4.9
EPS 4.7
Dividend 0.3
Relative Strength Index 63.08
Money Flow Index 83.03
MACD Signal 2.86
Average True Range 7.89

Themis Medicare Investment Rating

  • Master Rating:
  • Themis Medicare has an operating revenue of Rs. 370.32 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of 17% is great, ROE of 16% is good. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 26% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Themis Medicare Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 105978089919480
Operating Expenses Qtr Cr 92757074707465
Operating Profit Qtr Cr 12221015212014
Depreciation Qtr Cr 3333322
Interest Qtr Cr 2232222
Tax Qtr Cr 3424554
Net Profit Qtr Cr 71361214128
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 366401
Operating Expenses Annual Cr 287299
Operating Profit Annual in Cr 6796
Depreciation Cr 109
Interest Annual Cr 109
Tax Annual Cr 1622
Net Profit Annual Cr 4362
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1634
Cash from Investing Activity Annual Cr -24-16
Cash from Financing Annual Activity Cr 0-18
Net Cash Flow Annual Cr -81
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 282243
Fixed Assets Annual Cr 165147
Total Non Current Assets Annual Cr 190168
Total Current Assets Annual Cr 266215
Total Assets Annual Cr 456384
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 306265
ROE Annual % 1525
ROCE Annual % 2234
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2226
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 105978089919480
Operating Expenses Qtr Cr 92757074707465
Operating Profit Qtr Cr 12221015212014
Depreciation Qtr Cr 3333322
Interest Qtr Cr 2232222
Tax Qtr Cr 3424554
Net Profit Qtr Cr 1118813181710
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 366401
Operating Expenses Annual Cr 287299
Operating Profit Annual in Cr 6796
Depreciation Cr 109
Interest Annual Cr 109
Tax Annual Cr 1622
Net Profit Annual Cr 5773
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1634
Cash from Investing Activity Annual Cr -24-16
Cash from Financing Annual Activity Cr 0-18
Net Cash Flow Annual Cr -81
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 339287
Fixed Assets Annual Cr 165147
Total Non Current Assets Annual Cr 249214
Total Current Assets Annual Cr 265214
Total Assets Annual Cr 514428
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 369312
ROE Annual % 1725
ROCE Annual % 1829
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2226

Themis Medicare Technicals

EMA & SMA

Current Price
₹179.7
-2.15 (-1.18%)
pointer
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹170.02
  • 50 Day
  • ₹165.80
  • 100 Day
  • ₹161.52
  • 200 Day
  • ₹150.82
  • 20 Day
  • ₹166.96
  • 50 Day
  • ₹166.68
  • 100 Day
  • ₹163.41
  • 200 Day
  • ₹150.93

Themis Medicare Resistance and Support

PIVOT
₹184.79
Resistance
First Resistance 188.07
Second Resistance 194.28
Third Resistance 197.57
RSI 63.08
MFI 83.03
MACD Single Line 2.86
MACD 5.72
Support
First Resistance 178.57
Second Resistance 175.28
Third Resistance 169.07

Themis Medicare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 157,566 10,066,892 63.89
Week 220,084 12,679,016 57.61
1 Month 164,398 9,372,346 57.01
6 Month 58,175 3,231,639 55.55

Themis Medicare Result Highlights

Themis Medicare Synopsis

NSE-Medical-Generic Drugs

Themis Medicare Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 354.32 Cr. and Equity Capital is Rs. 9.20 Cr. for the Year ended 31/03/2023. Themis Medicare Ltd. is a Public Limited Listed company incorporated on 31/05/1969 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1969PLC001590 and registration number is 001590.
Market Cap 1,677
Sales 370
Shares in Float 3.04
No of funds 3
Yield 2.8
Book Value 5.95
U/D Vol ratio 0.3
LTDebt / Equity 10
Alpha 0.24
Beta 0.95

Themis Medicare

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 67.16%67.16%67.16%67.18%
Mutual Funds
Foreign Portfolio Investors 0.05%0.04%0.06%0.02%
Financial Institutions/ Banks 0.01%0.01%0.01%0.01%
Individual Investors 22.32%22.64%23.12%23.15%
Others 10.46%10.15%9.65%9.64%

Themis Medicare Management

Name Designation
Dr. Dinesh S Patel Chairman & Executive Director
Dr. Sachin D Patel Managing Director & CEO
Mr. Rajneesh Anand Non Executive Director
Mr. Hariharan Subramaniam Independent Director
Ms. Manjul Sandhu Independent Director
Mr. Bhaskar V Iyer Independent Director
Mr. Vijay G Agarwal Independent Director

Themis Medicare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Themis Medicare Corporate Action

Date Purpose Remarks
2023-11-04 Quarterly Results
2023-08-10 Quarterly Results (Revised) per share(17.5%)Final Dividend
2023-05-13 Audited Results, Dividend & Stock Split
2023-02-03 Quarterly Results
2022-11-07 Quarterly Results
Date Purpose Remarks
2023-10-10 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Themis Medicare MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 8

Themis Medicare FAQs

What is Share Price of Themis Medicare ?

Themis Medicare share price is ₹179 As on 11 December, 2023 | 11:44

What is the Market Cap of Themis Medicare ?

The Market Cap of Themis Medicare is ₹1653.7 Cr As on 11 December, 2023 | 11:44

What is the P/E ratio of Themis Medicare ?

The P/E ratio of Themis Medicare is 32.3 As on 11 December, 2023 | 11:44

What is the PB ratio of Themis Medicare ?

The PB ratio of Themis Medicare is 4.9 As on 11 December, 2023 | 11:44

Q2FY23